 |
|
|
| |
Once-Daily Doutegravir + Abacavir/Lamivudine is Superior to Efavirenz/Tenofovir/Emtricitabine in Treatment-Naïve HIV Subjects: 144-Week Results - SINGLE Study (ING114467)
|
| |
| |
Reported by Jules Levin
54th ICAAC Sept 5-9 2014, Washington DC
K Pappa, PharmD1, A Baumgartenm MD2, F Felizarta, MD3, E Florennce, MD4, J Portilla, MD5, SWalmsley, MD6, C Granier, DESS7, D Wong, MSc1, B Wynne, MD1
|
| |
|
|
|
|
|
